Our colleagues Amy Stricker-Hume, Francois Bergeron, and Louis-Georges Guy will be attending the 36th annual TCT of the Cardiovascular Research Foundation in Washington, DC on Oct. 27-30. Feel free to reach out to schedule a meeting to discuss your R&D program and how AccelLAB can support with our preclinical regulatory studies. #TCT2024 #cardiovascular #implants #medtech #regulatory
About us
AccelLAB is a one-stop integrated CRO dedicated to the preclinical assessment of medical devices under GLP compliance. Specialized in the fields of interventional cardiology, orthopedics, dental medicine, spine, neurology, gastroenterology, ENT, sports and regenerative medicine, our research center conducts safety and efficacy preclinical studies at its Boisbriand site located in the greater Montreal area, Canada. AccelLAB exercises a leadership role coordinating medical device preclinical services and offering an integrated approach to medical device studies with a commitment to scientific excellence, an appreciation of client-specific, and an understanding of regulatory considerations. The medical device industry is highly regulated and requires quality systems to be assessed for products to be manufactured. Highly specialized services under one roof: • Study designs from proof of concept to large-scale studies • Surgeries and interventions performed in well-equipped operating suites and catheterization labs • State-of-the-art imaging modalities including C-arm fluoroscopy, high-definition radiography, Micro-CT, MRI, CT-Scan, echocardiography, IVUS and OCT • On-site necropsy for comprehensive gross examination, tissue harvest and specimen fixation • Routine histology and undecalcified bone processing using “Exakt” micro-grinding & polishing • Histopathology, histomorphometry and clinical pathology (hematology and blood biochemistry) • Histopathology Reports produced by on-staff Veterinary Pathologists • Full Scientific Reports produced by Study Directors • Good Laboratory Practices (GLP) and Full Quality Assurance Unit (QAU) Successfully audited by the FDA twice (2012 and 2019), our research center is fully accredited by AAALAC and CCAC.
- Website
-
https://accellab.com/
External link for AccelLAB
- Industry
- Research Services
- Company size
- 51-200 employees
- Headquarters
- Boisbriand, Quebec
- Type
- Privately Held
- Founded
- 2024
- Specialties
- Medical Devices, Regulatory Testing, Interventional Cardiology, Orthopedics, Spine, Dental Medicine, ENT, Regenerative Medicine, Preclinical Testing, GLP, Histology, Histopathology, Histomorphometry, Imaging, Safety testing, Efficacy testing, Performance testing, Gastroenterology, Sports Medicine, Neurology, and Oncology
Locations
-
Primary
Get directions
1635 Lionel-Bertrand Blvd.
Boisbriand, Quebec J7H 1N8, CA
Employees at AccelLAB
Updates
-
Will you be in Chicago next week? Schedule to meet with Dr. Michel Assad during the 39th annual NASS week, the world’s largest spine meeting with the latest innovations from the industry. AccelLAB is a proud regular at NASS for the last 15 years. As always, feel free to reach out to discuss your R&D program and how we can de-risk & accelerate your access to market with our preclinical GLP-compliant studies. #NASS2024 #Chicago #medicaldevices #biomaterials #spinal #orthopedics #preclinical #implants #regulatorytesting #GLP #medtech North American Spine Society
-
Make sure to join our President, Dr. Louis-Georges Guy, who will be representing AccelLAB next week at #EuroPCR2024. Always pleased to reconnect in person with collaborators and friends, and supporting your R&D program with our preclinical regulatory models. #medtech #preclinical #implants #cardio #medicaldevices #valverepair #europcr #biomaterials #regulatory #cardiology #interventionalcardiology
EuroPCR
pcronline.com
-
AccelLAB reposted this
AccelLAB has a proud history of GLP-compliant study support and successful FDA inspections. Respect for the rigor of regulations and scientific integrity are hallmarks of our achievement dating back to our origins in 2004. Mitigate risk of delay at any phase of medical device development by partnering with us on your next preclinical study.
Fraudulent and Unreliable Laboratory Testing Data in Premarket Submiss
fda.gov
-
AccelLAB reposted this
AccelLAB has a proud history of GLP-compliant study support and successful FDA inspections. Respect for the rigor of regulations and scientific integrity are hallmarks of our achievement dating back to our origins in 2004. Mitigate risk of delay at any phase of medical device development by partnering with us on your next preclinical study.
Fraudulent and Unreliable Laboratory Testing Data in Premarket Submiss
fda.gov
-
New generation Resorbable Magnesium Scaffold from Biotronik now CE Marked!
✔️CE Marked! Introducing Freesolve: Metallic performance. Fully resorbable. Free… - from a permanent implant - for future treatment options - to simply be Discover the new generation Resorbable Magnesium Scaffold: 👉 https://ow.ly/xzv150QA9tE #BIOTRONIK #RMS #WhatWouldYouChoose #leavelessbehind
-
Our own science and research experts, Drs. Louis-Georges Guy and Michel Assad, will be attending the American Academy of Orthopaedic Surgeons (AAOS) this year. Feel free to reach out for a block of time to discuss supporting your innovation and R&D program with our preclinical GLP studies. #orthopedics #medicaldevices #medtech #biomaterials #preclinical #safety #efficacy #regulatory #aaos2024
-
-
Schedule to meet with Dr. Michel Assad next week during #ORS2024 in Long Beach, CA, as the society commemorates 70 years of advancing research in our field. You'll get to learn more about AccelLAB resuming its independent preclinical activities, and our regulatory study designs to support your access to market. Orthopaedic Research Society #orthopedics #preclinical #medicaldevices #biomaterials #regulatorytesting #medtech
-
-
BIG NEWS! A new day has come, and your recognized preclinical partner AccelLAB is back to serve your medical device evaluation needs. Your recognized entrepreneurial medical device preclinical research partners are back. After some time under the direction of Charles River Laboratories, key members of the management team acquired the group. Our AccelLAB medical device team of preclinical experts is proud to announce that we are returning with our entirely independent, turnkey contract research activities, managed by the same team you have grown to trust. Let’s rediscover together what has been the secret of our success since AccelLAB’s foundation. More than ever, we’re ready to support your R&D programs with safety, efficacy and performance evaluations. More than ever, we’re ready to support your access to the medtech market with the same commitment to scientific excellence, client-centric appreciation, and an understanding of regulatory considerations. Expect the interaction and dynamism, scientific rigor, and cost-effectiveness that you have known us for in the past. Thank you to all the partners that made this possible, including the Charles River team and Fairmount Partners, a leading investment bank in the pharma industry, who not only served as the exclusive financial advisor to Charles River Laboratories, but were also excellent partners for AccelLAB throughout this project. Welcome back to AccelLAB ! #medicaldevices #meddevices #preclinical #preclinicalresearch #implants #biomaterials #regulatorytesting #safetytesting #performancetesting #regulatory #medtech
-